Physician profile
Pradeep K Singh
NPI 1346284437
$14,590.06
in general payments reported to CMS, 2019-2025
36 companies · $1,901 in 2025
The $1,901 reported for 2025 was more than what 83% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,972 · 2020: $419 · 2021: $1,393 · 2022: $779 · 2023: $791 · 2024: $2,335 · 2025: $1,901.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,614 · Travel and Lodging: $1,413.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,613.79 |
| Travel and Lodging | $1,413.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $4,115.44 | 2019-2020 | |
| Boston Scientific Corporation | $1,778.33 | 2019-2025 | Watchman Access System, Avvigo Guidance System, General - Balloon Catheters |
| Abiomed | $1,120.88 | 2021-2025 | Impella |
| Abbott Laboratories | $595.18 | 2019-2025 | Dragonfly Opstar, Cardiomems, Amplatzer Talisman |
| Alexion Pharmaceuticals, INC. | $583.32 | 2021-2025 | Ultomiris |
| Janssen Pharmaceuticals, INC | $567.24 | 2019-2024 | Xarelto |
| Shockwave Medical, INC | $367.52 | 2021-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Pfizer INC. | $340.77 | 2019-2020 | |
| Penumbra, INC. | $338.52 | 2024 | Indigo System |
| Novartis Pharmaceuticals Corporation | $337.35 | 2019-2024 | |
| Astrazeneca Pharmaceuticals LP | $314.69 | 2019-2023 | Farxiga |
| Ekos Corporation | $294.41 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $286.74 | 2019-2025 | Camzyos |
| Amgen INC. | $286.55 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $260.93 | 2019-2022 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $226.29 | 2019-2020 | |
| Medtronic, INC. | $225.00 | 2021-2025 | Ffrangio, Micra |
| Atricure, INC. | $206.65 | 2021-2023 | |
| Inari Medical, INC. | $196.71 | 2021 | |
| Cardiovascular Systems INC. | $193.37 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $183.19 | 2019 | |
| Teleflex LLC | $183.01 | 2019-2024 | Turnpike |
| Regeneron Healthcare Solutions, INC. | $175.26 | 2019 | |
| Gt Medical Technologies, INC | $171.96 | 2025 | Gammatile |
| Chiesi USA, INC. | $168.28 | 2019-2020 | |
| Terumo Medical Corporation | $158.27 | 2019 | |
| W. L. Gore & Associates, INC. | $140.00 | 2022 | |
| Sirtex Medical INC | $128.01 | 2023 | Sir-Spheres Microspheres |
| Bayer Healthcare Pharmaceuticals INC. | $125.00 | 2024 | |
| Daiichi Sankyo INC. | $122.76 | 2021 | |
| Esperion Therapeutics, INC. | $122.15 | 2022 | |
| Astellas Pharma US INC | $104.37 | 2019-2020 | |
| Kestra Medical Technology Services, INC. | $73.87 | 2024 | Assure Wcd |
| Heartflow, INC. | $65.97 | 2021 | |
| Novo Nordisk INC | $27.10 | 2025 | |
| Elutia, INC. | $4.97 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pradeep Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.